NCT02680509View on ClinicalTrials.gov

Single-port Thoracoscopic Sympathicotomy for Treatment of Raynaud's Phenomenon, a Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
Raynauds
Interventions
PROCEDURE

Sympathicotomy R3

sympathicotomy R3 consists of transecting the sympathetic chain at the third costal level, cranial of the ganglia, leaving the ganglia themselves untouched

Trial Locations (1)

Unknown

University Medical Centre Groningen, Groningen

All Listed Sponsors
lead

Michiel Kuijpers

OTHER

NCT02680509 - Single-port Thoracoscopic Sympathicotomy for Treatment of Raynaud's Phenomenon, a Feasibility Study | Biotech Hunter | Biotech Hunter